The Pharma Legal Handbook: Slovakia

Slovakia is a European Union member state with a pharmaceutical regulatory framework administered by the State Institute for Drug Control (SUKL). As a CEE market with a well-functioning health insurance system, Slovakia is an important market for companies building a regional portfolio, and its pricing levels are frequently referenced by neighbouring markets.

Slovakia's reimbursement system operates through health insurance companies, with the Health Care Surveillance Authority (UDZS) overseeing the categorisation and pricing of reimbursable medicines. The process involves reference pricing to other EU markets and a managed entry agreement framework for innovative medicines.

The Pharma Legal Handbook: Slovakia provides comprehensive guidance on pharmaceutical regulation in Slovakia, covering SUKL product authorisation, reimbursement pathways, clinical trial requirements, pharmacovigilance obligations, manufacturing standards, marketing rules, parallel imports, and intellectual property protection.